DIANA MUMMERT: Open Payments
NPI 1295907764 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 66 payments from 10 companies in 2025. Trend: 2023 $1,372 · 2024 $1,034 · 2025 $1,097
Food & beverage: $1,097
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $362 |
| Otsuka America Pharmaceutical, Inc. | 18 | $356 |
| ABBVIE INC. | 12 | $184 |
| Lundbeck LLC | 5 | $86 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Tris Pharma Inc | 1 | $16 |
| Alkermes, Inc. | 1 | $15 |
| Corium, LLC | 1 | $7 |
Products named: REXULTI, CAPLYTA, VRAYLAR, SPRAVATO, FANAPT, COBENFY, Dyanavel XR, ARISTADA.
Industry payments across TX — which companies pay providers there.
